Skip to content
MatchScript
Menu

Head-to-head · The Match Score

CoreAge Rx vs TeleSlim Clinic

Both scored on the same six-factor Match Score. CoreAge Rx wins this matchup with a 91 to 57 edge.

Higher Match Score

CoreAge Rx

#1 · Grade A−

Anyone who wants transparent flat pricing, fast nationwide access, and no teaser-rate bait-and-switch.

Visit CoreAge Rx
VS

TeleSlim Clinic

#356 · Grade C

People who want md-supervised glp-1 care with transparent membership pricing in the midwest and select states.

Visit TeleSlim Clinic

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
82
48
Speed to Start
97
58
Formulary Match
80
40
Support Level
93
75
Flexibility
97
55
Transparency
95
68

Price, coverage & formulary

DetailCoreAge RxTeleSlim Clinic
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 states6 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjectable onlyInjectable only
Match Score91 · A−57 · C
Winner: CoreAge Rx

CoreAge Rx is our #1-ranked provider overall, and it takes this matchup too — a 91 Match Score to TeleSlim Clinic's 57. The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.

TeleSlim Clinic is still a fair pick if its strengths line up with yours — best for: People who want md-supervised glp-1 care with transparent membership pricing in the midwest and select states.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full CoreAge Rx reviewFull TeleSlim Clinic review

More head-to-heads

Or browse alternatives to CoreAge Rx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.